Latest news from Ablative Solutions on News en-us Copyright 2024 News 115 31 / /images/newswise-logo-rss.gif /articles/ablative-solutions-strengthens-its-scientific-advisory-board/?sc=rsin /articles/ablative-solutions-strengthens-its-scientific-advisory-board/?sc=rsin Tue, 06 May 2014 09:05:00 EST Ablative Solutions, Inc. (ASI), a privately held company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has added Paul Sobotka, MD, FACP, FACC, FAHA, a highly respected clinician, to its Scientific Advisory Board. The Company is developing a patented device for sympathetic nerve modulation, the Peregrine System(tm), which delivers treatment to the outer region of arteries, including renal arteries, where the sympathetic nerves are located. The interruption of these nerve pathways may have therapeutic implications for hypertension, metabolic syndrome, congestive heart failure and obesity. Ablative Solutions /articles/ablative-solutions-receives-fda-clearance-for-the-peregrine-system-infusion-catheter/?sc=rsin /articles/ablative-solutions-receives-fda-clearance-for-the-peregrine-system-infusion-catheter/?sc=rsin Wed, 02 Apr 2014 12:00:00 EST Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter. Ablative Solutions /articles/investors-express-confidence-in-ablative-solutions-approach-of-perivascular-renal-denervation-with-a-95m-series-b-financing/?sc=rsin /articles/investors-express-confidence-in-ablative-solutions-approach-of-perivascular-renal-denervation-with-a-95m-series-b-financing/?sc=rsin Tue, 04 Feb 2014 09:00:00 EST Ablative Solutions, Inc., a privately-held clinical stage company headquartered in Kalamazoo, MI, with offices in Menlo Park, CA, announced today that it has completed a Series B Preferred Stock financing, totaling approximately $9.5 million (including the conversion of the bridge financing completed in 2013), to fund its unique technology platform for renal denervation. The round was led by BioStar Ventures and Michigan Accelerator Fund, and included participation by the founders and multiple angel investors. "The Company has made tremendous progress in the two years since its inception with a unique approach to renal denervation, and has done so with great capital efficiency," affirmed Dale Grogan of Michigan Accelerator Fund, who was elected to the Company's Board of Directors upon closing of the financing. Ablative Solutions /articles/ablative-solutions-inc-receives-innovation-award-from-medical-main-street-at-inno-vention-2012/?sc=rsin /articles/ablative-solutions-inc-receives-innovation-award-from-medical-main-street-at-inno-vention-2012/?sc=rsin Tue, 09 Oct 2012 04:00:00 EST Ablative Solutions, Inc. (ASI), a privately-held company headquartered in Kalamazoo, MI with offices in Menlo Park, CA announced today that it was a recipient of Innovator of the Year award by Medical Main Street. Medical Main Street sponsors the Inno-vention 2012 conference, which brings together Michigan-based hospitals, research universities, pharmaceutical companies, medical device companies and researchers, with the goal of promoting innovation in the life sciences field. Ablative Solutions /articles/ablative-solutions-completes-53m-series-a-financing/?sc=rsin /articles/ablative-solutions-completes-53m-series-a-financing/?sc=rsin Tue, 19 Jun 2012 11:00:00 EST Ablative Solutions, Inc. (ASI), a privately-held company headquartered in Kalamazoo, MI with offices in Menlo Park, CA announced today that it has completed a Series A Preferred Stock financing, totaling approximately $5.3 million (including the conversion of the bridge financing completed earlier this year), to fund its unique technology platform. The round was led by BioStar Ventures and the Michigan Accelerator Fund, and included participation by multiple angel investors. Honigman Miller Schwartz and Cohn LLP served as legal advisor to ASI for the transaction. Ablative Solutions